3rd JAK Inhibitors Drug Development Summit

Tuesday, June 7, 2022 - 09:00 to Thursday, June 9, 2022 - 18:30 (GMT-4)

Following two successful virtual experiences, the 3rd JAK Inhibitors Drug Development Summit is making its way to Boston, MA warmly welcoming the JAK inhibitor community back to in-person meetings.

We are uniting this diverse community of world-leading experts from a range of therapeutic backgrounds all tied together by one thing, treating dermatologic, autoimmune, oncologic and many more inflammatory indications through JAK inhibition.

This remains the only end-to-end industry meeting committed to delivering new JAK inhibitor therapeutics to market through collaboration. This year's summit bestows an unrivaled prospect to industry experts; debating JAKi safety with benefit-risk conversations, exploring JAK selectivity to elevate precise approaches, reviewing opportunities to foray into indications of unmet need, and embracing discussion around topical/oral/alternate drug delivery methods to accelerate production of the next generation of JAK inhibitors.

Learn more, download your copy of the full event guide here: https://bit.ly/3sZOhFg

Event Information

Hanson Wade
In-person - Hilton Boston Logan Airport One Hotel Drive Boston, MA 02128 United States
This event is under the auspices of UICC
Last update: 
Wednesday 6 April 2022